allogeneic anti-a-GalCer/CD1d CAR type I NKT-cell therapy (Akeso Therapeutics)

N/A

ๆŠฅๅ‘Šๆ—ถ้—ด: 2025/03/14 16:20:43

ๅŸบๆœฌไฟกๆฏ

่ฏ็‰ฉๅ็งฐallogeneic anti-a-GalCer/CD1d CAR type I NKT-cell therapy (Akeso Therapeutics)
่ฏ็‰ฉๅˆซ็งฐN/A
่ฏ็‰ฉ็ฑปๅž‹็”Ÿ็‰ฉ่ฏ > ่›‹็™ฝ็ฑป่ฏ็‰ฉ > ้‡็ป„่›‹็™ฝ > ่žๅˆ่›‹็™ฝ็ป†่ƒžไธŽๅŸบๅ› ็–—ๆณ• > ็ป†่ƒž็–—ๆณ• > ๅ…็–ซ็ป†่ƒž็–—ๆณ• > ๆท‹ๅทด็ป†่ƒž็–—ๆณ• > T็ป†่ƒž็–—ๆณ• > ๅตŒๅˆๆŠ—ๅŽŸๅ—ไฝ“T็ป†่ƒž็–—ๆณ•๏ผˆCAR-T๏ผ‰
ไฝœ็”จๆœบๅˆถCD1dๆŠ—ๅŽŸ่ฐƒ่Š‚ๅ‰‚
้ถ็‚นCD1dๆŠ—ๅŽŸ
ๆฒป็–—้ข†ๅŸŸ / ้€‚ๅบ”็—‡่‚ฟ็˜ค
ๅ…จ็ƒๆ‰นๅ‡†้€‚ๅบ”็—‡N/A
ไธญๅ›ฝๆ‰นๅ‡†้€‚ๅบ”็—‡N/A
้ฆ–ๆ‰นๅ›ฝๅฎถ/ๅŒบๅŸŸN/A
้ฆ–ๆ‰นๆ—ฅๆœŸN/A
ๅ›ฝๅฎถ/ๅŒบๅŸŸ็พŽๅ›ฝ
ๆ˜ฏๅฆๅคๆ–นๅฆ
ๅ…จ็ƒๆœ€้ซ˜็ ”ๅ‘็Šถๆ€ไธดๅบŠๅ‰
ไธญๅ›ฝๆœ€้ซ˜็ ”ๅ‘็Šถๆ€N/A
ๅŽŸ็ ”ๅ…ฌๅธN/A
ๆณจๅ†Œๅˆ†็ฑปN/A

็ ”ๅ‘ไฟกๆฏ

ๆดป่ทƒๅ…ฌๅธ +[1]ย  N/A
้žๆดป่ทƒๅ…ฌๅธN/A
ๆดป่ทƒ้€‚ๅบ”็—‡่‚ฟ็˜ค
้žๆดป่ทƒ้€‚ๅบ”็—‡N/A

ๅ…ถไป–ไฟกๆฏ

ATCไปฃ็ N/A
็›ธๅ…ณ้“พๆŽฅN/A